Inicio > Enfermedades infecciosas > Incidencia de Rotavirus en lactantes ingresados en sala de Enfermedades Diarreicas > Página 10

Incidencia de Rotavirus en lactantes ingresados en sala de Enfermedades Diarreicas

REFERENCIAS BIBLIOGRÁFICAS:

1. Bishop RF, Davidson GP, Colmes IH, Ruck BJ.Virus particles in eptthelial cells of duodenal mucosa from children with acute nonbacterial gastroenteritis.Lancet 1973; 1: 1281 – 3.

2. Kosek M, Bern C, Guerrant RL. The magnitude of the global problem of diarrheal disease from studies published 1992-2000. Bull WHO 2003;81(3):197-200.

3. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrea. Emerg Infect Dis 2006;12(2):304-06.

4. Sánchez FA, Montero V, Moreno S, Solé M, Colomina J, Miren IG, et al. Human rotavirus G9 and G3 as major cause of diarrea in hospitalizad children, Spain. Emerg Infect Dis 2006;12(10):1536-41.

5. Fabre AR, Scarafía AT, Balbachan SE, Goya G, Alonso JM. Importancia de los rotavirus como agentes causantes de gastroenteritis infantil aguda en el área de Resistencia y Corrientes. Bol Inst Med Reg 2010;9(5):124-31.

6. Alerta epidemiológica: Actualización, diarreas por rotavirus. Organización Panamericana de la Salud. 19 de mayo 2010.

7. Fernández FM, Conner ME, Hodgins DC, Parwani AV, Nielsen et al. Passive immunity to bovine rotavirus in newborn claves fed colostrums supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine, 2008 Mar;16(5):507-16.

8. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations or the Advisory Committee on Immunization Practices (APIC). Morb Mortal Wkly Rep 2009, Mar 19;48(RR-20):1-20.

9. Block VT, Goveia M, Rivers S, et al. Efficacy, immunogenicity, and safety of a polyvalent rotavirus vaccine (RotaTeq) at expiry potency in healthy infants. In: National Immunization Conference. Washington, DC; 2005.

10. Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004;144(2):184-90.

11. Goveia M, Hastings P, Rodriguez Z, Dallas M, Boslego J and Heaton P. Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine (RotaTeq®) in premature infants. 40th National Immunization Conference (NIC).Atlanta, Georgia. USA. March 6-9 2006.

12. Offit P, Clark HF. Rotateq: A pentavalent bovine -human reassortant rotavirus vaccine. Pediatric Annals 35(1):29-34, 2006

13. FDA Public Health Notification. Information on RotaTeq and Intussusception.Disponible en: URL:http://www.fda.gov/cber/safety/phnrota021307.htm

14. CDC. Intussusception and RotaTeq vaccine. Disponible en:URL:-http://www.cdc.gov/od/science/iso/concerns/rotavirus.htm

15. WHO. Statement on RotaTeq vaccine and Intussusception. Disponible en URL:http://www.who.int/vaccine_safety/topics/rotavirus/rotateq_statement/en/index.html

16. Kane EM, Turcios RM, Arvay ML, García S, Bresee J, Glass RI. The epidemiology of rotavirus diarrea in Latin America: Anticipating vaccines. Rev Panam Salud Púb 2008;16(6):371-7.

17. Angela Gentile, Miriam Bruno, José Marcó del Pont, Alejandro Ellis, Charlotte Russ, Raul Ruvinsky y cols. Gastroenteritis por rotavirus y su prevención. Archivos Argentinos de Pediatría. V 104 n.6 Buenos Aires nov/dic 2006

18. María González, Roxana Hidalgo, Lis Silva. Rotavirus: Enfermedad emergente de transmisión digestiva. Revista Cubana de Pediatría. 2003 v.75 n.1 Ciudad de La Habana ene-abr. 2003.

19. Coutín Marie G, Morales Polanco I, Rodríguez Milord D, Aguiar Prieto PH. Morbilidad oculta por enfermedades diarreicas en Cuba. Reporte Técnico de Vigilancia 2005

20. Bresee J, Zhao-Yin F, Bei W, Nelson EA, Tam J, Soenarto Y, et al. Firts report from the Asian rotavirus surveillance Network. Emerg Infect Dis 2004;10(6):988-95.

21. Yoshinaga M, Phan TG, Nguyen TA, Yan H, Yagyu F, Okitsu S, et al. Changing distribution of group A rotavirus G-types and genetic analysis of G9 circulating in Japan. Arch Virl 2006;151(1):183-92.

22. Castelló AA, Argüelles MH, Rota PR, Oltoff A, Jiang B, Glass RI, et al. Molecular epidemiology of group A rotavirus diarrea among children in Buenos Aires, Argentina, from 2000 to 2003 and the emergente of the genotype G12. J Clin Microbiol 2006;44(6):2046-50.

23. . Kebaabetswe LP, Sebunya TK, matsheka MI, Ndungu T. Detection and molecular characterisation of group A rotavirus from children in northem Botswana. East Afr Med J 2005;82(4):203-08.

24. Navrongo Rotavirus Research Group. Incidente and risk factors of paediatric rotavirus diarrhoea in Northern Ghana. Tropl Med Intern Health 2003;8(9):840-6.

25. Giordano MO, Ferreyra LJ, Isa MB, Martínez LC, Yudowsky SI, Nates SV. The epidemiology of acute viral grastroenteritis in hospitalized children in Cordoba city, Argentina: An insight of disease burden. Rev inst Med Trop Sao Paulo 2005;43(4):193-7.

26. Sonza S, Breschkin AM, Holmes IH: The major surface glycoprotein of simian rotavirus (SA 11) contains distinct epitopes. Virology 2003;134:318-27.

27. Nakata J, Gatheru Z, Ukae S, Adachi N, Kobayashi N, Honma S, et al. Epidemiological study of the G serotype distribution of group A rotaviruses in Kenya from 1991 to 1994. J Med Virol 1999;58(3):296-303.

28. Kantharidis P, Dyall-Smit LM, Holmes HI. Completion of The genecoding assements of SA 11 rotavirus: gene products of segments 7,8 and 9. J Virol 2003;48:330-4.

29. Kalica AR, Flores J, Greenberg HB. Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 2007;125:194-205.

30. Theil KW, Birch, CJ. Pathogenesis of porcine rotaviral infection in experimentally inoculed gnotobiotic pigs. Am J Vet Res 1978;39:213-20.

31. Jourdan N, Brunet JP, Spain C, Blais A, Cotte Laffitte J, Forestier F, et al. Rotavirus infection reduces sucrose-isomaltase expression in human intestinal epithelial cell by perturbing protein targeting and organization of microvillar cytoskeleton J Virol 2006:72(9):1728-36.

32. Nabuurs MJ. Weaning piglets as a model for studying pathophysiology of diarrhea. Vet O 1998;20(30):542-5.

33. Weclewicz K, Svensson L, Keistensson K. Targeting of endoplasmic reticulumas sociated proteins to axons and dendrites in rotavirus-infected neurons. Brain Res Bull 2009, Jul;46(4):353-60.

34. Owen Matson D. Monograph: The management and prevention of rotavirus. 2006

35. Ramachandran M, Vij A, Kumar R. Lack of maternal antibodies to P serotypes may predisponse neonates to infections with unusual rotavirus strains. Clin Diagn Lab Immunol 2006 5(4):527-30.

36. Rose JR, Williams MB, Rott LS, Butcher EC, Greenberg HB. Expression of mucosal homing receptor alpha4 beta 7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol 2008;72(2):726-30.